| 摘要 |
<p>SH3 domain binding inhibitors containing, as the active ingredient, nonpeptidic compounds having an activity of inhibiting SH3 domain binding, low-molecular weight compounds having an activity of inhibiting SH3 domain binding and a molecular weight of less than 750, in particular, compounds represented by the above general formulae (I) and (II), cytochalasins or pharmacologically acceptable salts thereof; and compounds represented by the above general formulae (Va), (Vb) and (VI) and pharmacologically acceptable salts thereof.</p> |
